Hepatology - Hepatology Xagena

Hepatology

News

Drugs

Xagena Medicine

Xagena.net

Sebivo has achieved primary endpoint in GLOBE trial in patients with chronic hepatitis B

Pegasys as a first-line therapy in chronic hepatitis B

Autoimmune hepatitis with no symptoms: therapy may not be necessary

Children with maple syrup urine disease: developed comprehensive protocol for liver transplant

HCV infection: transmission among family members

HCV infection: how virus evades the body’s immune system

Protease inhibitors: VX-950 reduces viral levels in patients with chronic HCV infection

A study evaluates Trental in nonalcoholic steatohepatitis

Leukemia: genes linked to treatment resistance in children

Liver damage: obstructive sleep apnea may be a risk factor

Pegasys for the treatment of chronic hepatitis B, FDA approved

Peg-Intron plus Rebetol in children and adolescents with chronic hepatitis C

Chronic hepatitis B: FDA has approved Baraclude

Europe: Pegasys approved for the treatment of chronic hepatitis B

Next Pages 1 [2]

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions